| Breakdown | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 437.30M | 420.40M | 400.00M | 317.60M | 268.60M |
| Gross Profit | 176.80M | 164.30M | 154.20M | 128.10M | 118.60M |
| EBITDA | 72.90M | 65.90M | 63.80M | 55.70M | 53.80M |
| Net Income | 47.10M | 39.70M | 38.50M | 33.90M | 27.80M |
Balance Sheet | |||||
| Total Assets | 514.20M | 432.90M | 401.70M | 377.50M | 336.30M |
| Cash, Cash Equivalents and Short-Term Investments | 81.60M | 64.80M | 53.60M | 53.60M | 68.70M |
| Total Debt | 48.00M | 4.60M | 4.90M | 5.80M | 4.40M |
| Total Liabilities | 168.60M | 115.30M | 109.00M | 108.70M | 88.10M |
| Stockholders Equity | 338.00M | 317.60M | 292.70M | 268.80M | 244.50M |
Cash Flow | |||||
| Free Cash Flow | 22.10M | 29.10M | 30.70M | 21.30M | 38.40M |
| Operating Cash Flow | 52.50M | 48.30M | 48.50M | 35.90M | 43.40M |
| Investing Cash Flow | -25.10M | -39.30M | -8.10M | -71.50M | -9.00M |
| Financing Cash Flow | 12.60M | -21.20M | -19.70M | -20.20M | -15.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £717.55M | 9.21 | 14.27% | 2.74% | 3.97% | 34.09% | |
75 Outperform | £15.78B | 17.33 | 28.56% | 1.96% | 6.00% | 42.42% | |
72 Outperform | £337.83M | 16.26 | 23.59% | 3.39% | 3.04% | -6.67% | |
65 Neutral | £450.84M | 9.36 | 3.72% | 4.05% | -2.22% | ― | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | £950.10M | 43.61 | 9.32% | 2.11% | -6.03% | 13.11% | |
43 Neutral | £127.02M | -3.34 | -1.06% | 5.22% | -0.79% | 87.50% |